On November 11, 2024, Novo Nordisk A/S disclosed share transactions involving its Executive Vice President, David Moore, who acquired 18,634 shares at DKK 0.00 and sold 9,919 shares for DKK 759.96 each, totaling approximately DKK 7.54 million.